Topics And Speakers:
Session Description
This Early Program session includes approximately 11 hours of pre-recorded content which is made available to participants on October 14 at noon EDT through December 4, 2020.

Presentations
Management of Nephrotic Syndrome
12:00 PM EDT – 12:00 PM EDT
Rupali S. Avasare, MD
Pathology of FSGS and Membranous Nephropathy
12:00 PM EDT – 12:00 PM EDT
Cynthia C. Nast, MD, FASN
Management of Minimal Change Disease and FSGS
12:00 PM EDT – 12:00 PM EDT
J. Ashley Jefferson, MD, FASN
Management of Membranous Nephropathy
12:00 PM EDT – 12:00 PM EDT
Laurence H. Beck, MD, PhD
Glomerular Disease in Children
12:00 PM EDT – 12:00 PM EDT
Rasheed A. Gbadegesin, MD, MBBS, FASN
Pathology and Classification of C3 Glomerulopathy and Thrombotic Microangiopathy
12:00 PM EDT – 12:00 PM EDT
Cynthia C. Nast, MD, FASN
Complement in C3 Glomerulopathy and Common Kidney Diseases
12:00 PM EDT – 12:00 PM EDT
Joshua M. Thurman, MD
Precision Medicine in Glomerular Disease
12:00 PM EDT – 12:00 PM EDT
Sharon G. Adler, MD, FASN
Pathology of Dysproteinemias
12:00 PM EDT – 12:00 PM EDT
Glen S. Markowitz, MD
Management of Dysproteinemias
12:00 PM EDT – 12:00 PM EDT
Jonathan Hogan, MD
Management of ANCA-Associated Vasculitis
12:00 PM EDT – 12:00 PM EDT
Rachel B. Jones, MD, MBBS
APOL1: A Therapeutic Target in Glomerular Disease
12:00 PM EDT – 12:00 PM EDT
Jeffrey B. Kopp, MD, FASN
IgA Nephropathy
12:00 PM EDT – 12:00 PM EDT
Heather N. Reich, MD, PhD
Glomerular Disease in Pregnancy
12:00 PM EDT – 12:00 PM EDT
Liz Lightstone, MBBS, PhD
Update on Diabetic Kidney Disease
12:00 PM EDT – 12:00 PM EDT
Katherine R. Tuttle, MD, FASN
Management of Lupus Nephritis
12:00 PM EDT – 12:00 PM EDT
Brad H. Rovin, MD, FASN